Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Salutatory Oral Prednisolone Dosing on Cancer Pain WHO Stepladder Analgesic Drug Protocol

NCT04162379 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT04162379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04162379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Salutatory Oral Prednisolone Dosing on Cancer Pain WHO Stepladder Analgesic Drug Protocol
Lead sponsor
Mansoura University
Phase
Phase 2
Overall status
Completed
Start date
November 15, 2019
Completion date
March 1, 2020
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

steroid anlgesia in cancer pain